Niraparib Extends Time Without Symptoms in Ovarian Cancer

Findings based on phase 3 study of maintenance therapy with PARP inhibitor following treatment
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Conference News, Source Type: news